Kansas Statutes 39-7,118. Drug utilization review program
Terms Used In Kansas Statutes 39-7,118
- Assistance: includes such items or functions as the giving or providing of money, food assistance, food, clothing, shelter, medicine or other materials, the giving of any service, including instructive or scientific. See Kansas Statutes 39-702
- Contract: A legal written agreement that becomes binding when signed.
- Department: means the department of health and environment. See Kansas Statutes 39-7,116
- Medical assistance: means the payment of all or part of the cost of necessary: (1) Medical, remedial, rehabilitative or preventive care and services that are within the scope of services to be provided under a medical care plan developed by the secretary pursuant to this act and furnished by health care providers who have a current approved provider agreement with the secretary; and (2) transportation to obtain care and services that are within the scope of services to be provided under a medical care plan developed by the secretary pursuant to this act. See Kansas Statutes 39-702
- Recipient: means a person who has received assistance under the terms of this act. See Kansas Statutes 39-702
- Secretary: means the secretary for children and families, unless otherwise specified. See Kansas Statutes 39-702
- State: when applied to the different parts of the United States, includes the District of Columbia and the territories. See Kansas Statutes 77-201
The secretary of health and environment shall implement a drug utilization review program with the assistance of a medicaid drug utilization review board as provided in Kan. Stat. Ann. § 39-7,119, and amendments thereto, to assure the appropriate utilization of drugs by patients receiving medical assistance under the medicaid program. The drug utilization review program shall include:
(a) Monitoring of prescription information including overutilization and underutilization of prescription-only drugs;
(b) making periodic reports of findings and recommendations to the secretary of health and environment and the United States department of health and human services regarding the activities of the board, drug utilization review programs, summary of interventions, assessments of education interventions and drug utilization review cost estimates;
(c) providing for prospective and retrospective drug utilization review, as specified in the federal omnibus budget reconciliation act of 1990 (public law 101-508);
(d) monitoring provider and recipient compliance with program objectives;
(e) providing educational information on state program objectives, directly or by contract, to private and public sector health care providers to improve prescribing and dispensing practices;
(f) reviewing the increasing costs of purchasing prescription drugs and making recommendations on cost containment;
(g) reviewing profiles of medicaid beneficiaries who have multiple prescriptions above a level specified by the board; and
(h) recommending any modifications or changes to the medicaid prescription drug program.